Have a personal or library account? Click to login
Challenges and Variables Affecting the Success of Sentinel Lymph Node Biospy in Malignant Melanoma a 4-Year Analysis of Clinical Results Cover

Challenges and Variables Affecting the Success of Sentinel Lymph Node Biospy in Malignant Melanoma a 4-Year Analysis of Clinical Results

Open Access
|Nov 2016

References

  1. 1. Wikipedia, the Free Encyclopedia [Internet], Melanoma, [cited 2013Jan 18]. Available from: http://en.wikipedia.org/wiki/Melanoma
  2. 2. Dimitrova N, Vukov M, Valerianova Z, editors. Cancer incidence in Bulgaria 2009. Vol XX. Bulgarian National Cancer Registry: Publisher “AVIS-24” Ltd.; 2011.
  3. 3. North JH Jr, Spellman JE. Role of sentinel node biopsy in the management of malignant melanoma. Oncology (Huntington). 1996; 10(8): 1237-42.
  4. 4. Lingam MK, Mackie RM, McKay AJ. Intraoperative identification of sentinel node in patients with malignant melanoma. Br J Cancer. 1997;75( 10): 1505-8.10.1038/bjc.1997.257
  5. 5. James WD, Berger TG, Elston DM. Melanocytic nevi and neoplasms. In: Andrews' Diseases of the Skin: Clinical Dermatology. 11th ed. Saunders Elsevier; 2011.p.675-93.10.1016/B978-1-4377-0314-6.00030-9
  6. 6. Sanchez RL, Raimer S. Pigmentary disturbances and melanocytic tumors. In: Sanchez RL, Raimer S, editors. Vademecum Dermatopathology. Georgetown, Texas: Landes Bioscience: 2001. p. 270-85.
  7. 7. Marghoob AA, Koenig K, Bittencourt FV, Kopf AW, Bart RS. Breslow thickness and Clark level in melanoma: support for including level in pathology reports and American Joint Committee on Cancer Staging. Cancer. 2000;88(3):589-95.10.1002/(SICI)1097-0142(20000201)88:3<;589::AID-CNCR15>3.0.CO;2-I
  8. 8. Testoril A, Rutkowski P, Marsden J, Bastholt L, Chiarion-Sileni V, Hauschild A, et al. Surgery and radiotherapy in the treatment of cutaneous melanoma. Ann Oncol. 2009;20(Suppl 6):vi22-vi29.10.1093/annonc/mdp257
  9. 9. Jakub JW, Pendas S, Reintgen DS. Current Status of Sentinel Lymph Node Mapping and Biopsy: Facts and Controversies. Oncologist. 2003;8(1): 59-68.10.1634/theoncologist.8-1-59
  10. 10. McKenna DB, Marioni JC, Lee RJ, Prescott RJ, Doherty VR. A comparison of dermatologists', surgeons' and general practitioners' surgical management of cutaneous melanoma. Br J Dermatol. 2004; 151 (3):636-44.10.1111/j.1365-2133.2004.06065.x
  11. 11. Morton DL, Thompson JF, Essner R, Elashoff R, Stem S, Nieweg O, et al. Validation of the accuracy of intraoperative lymphatic mapping and sentinel lymphadenectomy for early-stage melanoma. Ann Surg. 1999;230(4):453-63.10.1097/00000658-199910000-00001
  12. 12. Bostick P, Esner R, Glass E. Comparison of Blue Dye and Probe-Assisted Intraoperative Lymphatic Mapping in Melanoma to Identity Sentinel Nodes in 100 Lymphatic Basins. Arch Surg. 1999; 134(l):43-9.10.1001/archsurg.134.1.43
  13. 13. O’Brien CJ, Uren RF, Thompson JF, Howman-Giles RB, Petersen-Schaefer K, Shaw HM, et al. Prediction of potential metastatic sites in cutaneous head and neck melanoma using lymphoscintigraphy. Am J Surg. 1995; 170(5):461 -6.10.1016/S0002-9610(99)80330-4
  14. 14. Uren RF, Howman-Giles R, Thompson JF. Patterns of Lymphatic Drainage from the Skin in Patients with Melanoma. J Nucl Med. 2003;44(4):570-82.
Language: English
Page range: 112 - 117
Submitted on: Jul 1, 2013
Accepted on: Dec 27, 2013
Published on: Nov 30, 2016
Published by: Sciendo
In partnership with: Paradigm Publishing Services
Publication frequency: 2 times per year

© 2016 Dobromir D. Dimitrov, Veselin I. Kirov, Borislav A. Ignatov, Boris D. Tsankov, Hyuliya E. Feradova, Vasya Vutova, Silviya P. Hristova, Vasil D. Nanev, Genoveva B. Valcheva, Tashko S. Deliyski, published by Sciendo
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.